C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
OWLT Equity

OWLT

OTCMKTS · OWLT

$5.20
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
48/100 composite
Fundamentals62
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Owlet maintains a Neutral rating with a composite score of 48.5, reflecting an environment where positive fundamental aspects are counterbalanced by challenging market and regulatory contexts. The fundamentals pillar is the strongest, driven by robust gross margins, with regulatory and market pillars trailing in support. The overall conviction rating stands at 1 out of 5, indicating low confidence in significant market-beating performance at this time. Given the company's stretched financial condition, caution is advised when considering the broader financial landscape.

Revenue growth year-over-year shows moderate improvement, though operating margins remain firmly negative. Primary regulatory filings fail to suggest any immediate positive enforcement developments, contributing to a lukewarm regulatory outlook. Despite solid gross margin metrics, the ongoing net income losses challenge long-term sustainability. The company does not benefit from recent market price advancements, with institutional pricing feeds lacking updated quote data, which points to subdued market interest. Filing cadences similarly reflect this lethargy, with incomplete timely submissions.

Looking forward, investors should monitor fundamental developments closely. The company's gross margin potential enables a buffer against adverse shifts, providing a foothold in navigating fiscal uncertainties. Enhancements in revenue growth or significant operating margin improvements would be pivotal in strengthening Owlet's financial posture. Keeping an eye on how Owlet manages its financial condition in upcoming fiscal periods will be crucial for investors assessing new entry points. The fundamental pillar remains the strongest driver, and any shifts in this area may signal a broader strategic turn for Owlet.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
2940 WEST MAPLE LOOP DRIVE, SUITE 203, LEHI, UT, 84048
Phone
8443345330
CEO
Kurt Workman
CFO
Amanda Twede Crawford
Auditor
Salt Lake City
SEC CIK
1816708
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$177.0M
Enterprise value
$173.2M
Price to book
7.69
Price to sales
1.65
EV / EBITDA
-0.61
Revenue (TTM)
$107.1M
Gross profit (TTM)
$54.4M
EBITDA
$-10.9M
Operating margin
-24.4%
Profit margin
-43.0%
Rev growth YoY
6.4%
Return on equity
-526.2%
Return on assets
-10.0%
EPS (TTM)
$-2.57
EPS est. current year
$0.13
Wall St. target price
$13.00
Shares outstanding
29.1M
Insider ownership
10.5%
Institutional ownership
74.5%
Beta
1.84
Full-time employees
108
GICS sector
Healthcare
GICS industry
Medical Devices
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for OWLT (OWLT)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for OWLT (OWLT), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for OWLT are maintained by Cannabis Investor News and refreshed throughout the trading day.